ClinicalTrials.Veeva

Menu

VR Interventions to Reduce the Prevalence of Delirium in ICU Patients

Chinese Academy of Medical Sciences & Peking Union Medical College logo

Chinese Academy of Medical Sciences & Peking Union Medical College

Status

Enrolling

Conditions

Delirium

Treatments

Device: VRFS

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this clinical trial is to learn the effect of VR-based Family Support System (VRFS) on reducing delirium in ICU mechanically ventilated patients. The main question it aims to answer is:

·Using VRFS for participant intervention, can it reduce the incidence of delirium and improve clinical outcomes?

Researchers will investigate whether the implementation of VRFS can reduce the number of delirium days and improve clinical outcomes.

Participants will:

  • Receive the VRFS intervention until the endotracheal tube (ETT) is removed.
  • Have physiological data collected, including EEG, oxygen saturation levels, ECG, and blood pressure.
  • Keep a diary of delirium, dosage of sedative and analgesic drugs, the duration of mechanical ventilation, and ICU stays.

Full description

During the VRFS interventions, researchers will fit participants with a VR headset and noise-canceling headphones, shielding them from the ICU environment while allowing family members to be present and offer companionship and comfort.

Enrollment

102 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Mechanical ventilation duration is expected to be greater than 24 hours;
  • ICU stay duration is expected to be greater than 72 hours;
  • Age is 18 years or older, with no upper age limit;
  • Language: Chinese. Exclusion Criteria
  • Severe visual or auditory impairments (diplopia, low vision due to macular degeneration, retinopathy; severe hearing loss or deafness);
  • Cognitive and consciousness disturbances prior to ICU admission;
  • Severe motion sickness;
  • Head trauma or surgery that prevents the wearing of equipment;
  • A history of long-term use of antipsychotic and/or benzodiazepine medications.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

102 participants in 2 patient groups

VRFS Intervention
Experimental group
Description:
Participants will receive standard ICU care and will also undergo VRFS intervention.
Treatment:
Device: VRFS
Standard ICU Care
No Intervention group
Description:
Patients will be treated with standard ICU care and not receive VR stimulation.

Trial contacts and locations

1

Loading...

Central trial contact

Yingying Yang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems